Evidence for strong electron-phonon coupling and polarons in the optical response of La_{2-x}Sr_xCuO_4

The normal state optical response of La_{2-x}Sr_xCuO_4 is found to be consistent with a simple multi-component model, based on free carriers with strong electron-phonon interaction, localized polaronic states near 0.15 eV and a mid-infrared band at 0.5 eV. Normal state reflectance and absorbance of La_{1.83}Sr_{0.17}CuO_4 are investigated and their temperature dependence is explained. Both, the ac and dc response are recovered and the quasi-linear behavior of the optical scattering rate up to 3000- 4000 cm^{-1} is found to be consistent with strong electron-phonon interaction, which also accounts for the value of T_c. Although not strictly applicable in the superconducting state, our simple model accounts for the observed penetration depth and the optical response below T_c can be recovered by introducing a small amount of additional carriers. Our findings suggest that the optical response of La_{2-x}Sr_xCuO_4 could be explained both, in the normal and superconducting state, by a simple multi-fluid model with strong electron-phonon interaction if the gap symmetry and the temperature dependence of the 0.5 eV mid-infrared band are adequately taken into account.Comment: 22 pages, REVTeX, 12 figures in ps-fil

Spectral Photon-Counting Computed Tomography (SPCCT): in-vivo single-acquisition multi-phase liver imaging with a dual contrast agent protocol

International audienceAbstract Background Optimal treatment of prosthetic joint infection and chronic osteomyelitis consists of surgical removal of biofilm-embedded bacteria, followed by a 6–12 week course of antimicrobial therapy. However, when optimal surgery is not feasible, oral prolonged suppressive antibiotic therapy (PSAT) is recommended to prevent prosthesis loosening and/or relapse of infection. Since 2010, we have used infection salvage therapy using off-label subcutaneous (sc) injection of a β-lactam as PSAT for patients in whom oral PSAT is not possible. Methods A single-centre prospective cohort study (2010–18) reporting treatment modalities, efficacy and safety in all patients receiving sc PSAT. NCT03403608. Results The 10 included patients (median age 79 years) had polymicrobial (n = 5) or MDR bacterial (n = 4) prosthetic joint infection (knee, n = 4; hip, n = 3) or chronic osteomyelitis (n = 3). After initial intensive therapy, seven patients received ertapenem, three patients received ceftriaxone and one patient received ceftazidime by sc injection (one patient received 8 days of ceftriaxone before receiving ertapenem). In one patient, sc PSAT failed with recurrent signs of infection under treatment. In three patients, sc PSAT had to be discontinued due to side effects; in only one of these was the sc route implicated (skin necrosis following direct sc injection and not gravity infusion). Median treatment duration was 433 days. In six patients, sc PSAT was successful with favourable outcome at the time of writing. Interestingly, three patients with MDR bacterial carriage at baseline lost this under PSAT during follow-up. Conclusions As salvage therapy, sc PSAT delivered by gravity infusion is a safe and interesting alternative when an optimal surgical strategy is not feasible and no oral treatment is available

MADplots: A methodology for visualizing and characterizing energy-dependent attenuation of tissues in spectral computed tomography

Rationale and objectives: A method for visualizing and analyzing the complete information contained in spectral CT scans using two-dimensional histograms (i.e. Material Attenuation Decomposition plots – MADplots) of the water-photoelectric attenuation versus water-scatter attenuation at the cohort (combination of multiple studies across patients), examination, series, slice, and organ/ROI levels is described. Materials and methods: The appearance of a MADplot with several standard biological materials was predicted using ideal material properties available from NIST and the ICRU to generate a map for this non-spatial data space. Software tools were developed to generate MADplots as new DICOM series that facilitate spectral analysis. Illustrative examples were selected from an IRB-approved, retrospective cohort of Spectral Basis Images (SBIs) scanned using a pre-release, dual-layer detector spectral CT. Results: By combining all of the voxels for contrast and non-contrast studies, the predicted appearance of the MADplot was confirmed. Locations of several kinds of tissue, the shape of the tissue distributions in normal lung, and the variations in the manner in which organ-specific MADplots change with pathology are demonstrated for the presence of fat in both the liver and pancreas highlighting the potential use for identifying pathologies on spectral CT images. Conclusions: The examples of MADplots shown at cohort (combined studies), examination, series, slice, organ, and ROI levels illustrate their potential utility in analyzing and displaying spectral CT data. Future studies are directed at developing MADplot based organ segmentation and the automated detection and display of organ based pathologies

Feasibility of lung imaging with a large field-of-view spectral photon-counting CT system

International audienceAbstract Aims In low-gradient aortic stenosis (LGAS), the high valvulo-arterial impedance observed despite low valvular gradient suggests a high vascular load. Thoracic aortic calcifications (TACs) and valvular aortic calcifications (VACs) are, respectively, surrogates of aortic load and aortic valvular gradient. The aim of this study was to compare the respective contributions of TAC and VAC on 3-year cardiovascular (CV) mortality following TAVI in LGAS vs. high-gradient aortic stenosis (HGAS) patients. Methods and results A total of 1396 consecutive patients were included. TAC and VAC were measured on the pre-TAVI CT-scan. About 435 (31.2%) patients had LGAS and 961 (68.8%) HGAS. LGAS patients were more prone to have diabetes, coronary artery disease (CAD), atrial fibrillation (AF), and lower left ventricular ejection fraction (LVEF), P<0.05 for all. During the 3 years after TAVI, 245(17.8%) patients experienced CV mortality, 92(21.6%) in LGAS and 153(16.2%) in HGAS patients, P=0.018. Multivariate analysis adjusted for age, gender, diabetes, AF, CAD, LVEF, renal function, vascular access, and aortic regurgitation showed that TAC but not VAC was associated with CV mortality in LGAS, hazard ratio (HR) 1.085 confidence interval (CI) (1.019–1.156), P=0.011, and HR 0.713 CI (0.439–1.8), P=0.235; the opposite was observed in HGAS patients with VAC but not TAC being associated with CV mortality, HR 1.342 CI (1.034–1.742), P=0.027, and HR 1.015 CI (0.955–1.079), P=0.626. Conclusion TAC plays a major prognostic role in LGAS while VAC remains the key in HGAS patients. This confirms that LGAS is a complex vascular and valvular disease

First In-Human Results of Computed Tomography Angiography for Coronary Stent Assessment With a Spectral Photon Counting Computed Tomography

International audienc

Coronary CT Angiography with Photon-counting CT: First-In-Human Results

International audienc